Functional Diagnostics in Delaware

hearX Group develops and distributes digital hearing health technology for clinical, screening, occupational, and retail applications. The company specializes in evidence-based, clinically-validated digital audiometry solutions that enable hearing assessment without requiring soundproof booths, reducing time and infrastructure costs. Products serve multiple market segments: clinical settings for patient care enhancement, workplace hearing conservation programs for regulatory compliance, population-level hearing screening for early detection and intervention, and retail environments offering in-store and online hearing testing. The company is FDA-registered, ISO 13485 certified, HIPAA compliant, SOC 2 Type II certified, and holds registrations with SAHPRA and compliance certifications including GDPR and POPIA. Manufacturing and service capabilities include software development for digital diagnostics, cloud-based data management, and support for multi-user clinical workflows. The company operates U.S. headquarters in DeKalb, Illinois, with additional operations in South Africa.

NovaSight Inc. is a pediatric vision care company specializing in eye-tracking technology and data analytics for the digital assessment and treatment of childhood vision disorders. The company develops objective, non-invasive vision screening and treatment platforms designed for children, leveraging optical infrared sensors that track gaze position 90 times per second combined with proprietary artificial intelligence and big data analytics. NovaSight's primary products include CureSight, a remote digital amblyopia (lazy eye) treatment system, and TrackSight, a myopia management and prevention platform. Both solutions utilize ActiveSight™ proprietary glasses with remote-controlled occlusion and distance/tilt measurement capabilities. The technology eliminates reliance on patient cooperation or operator skill variability, delivering greater accuracy and repeatability than traditional vision assessment methods. Products are designed as child-friendly, entertaining activities that reduce chair time and assessment duration while providing objective clinical insights. The company positions its solutions for ophthalmologists, optometrists, and pediatric eye-care providers globally, with particular focus on pediatric populations. Core technological assets include eye-tracking sensors, proprietary active glasses, AI-driven analytics platforms, and vision population norm databases. The company engages with major professional conferences including AAPOS (American Academy of Pediatric Ophthalmology and Strabismus) annual meetings, indicating clinical validation within the pediatric ophthalmology specialty.